Table 2.
Vaccination coverage for five vaccination strategies evaluated [7, 10]. Based on National 2009 H1N1 Flu Survey (NHFS) [8], the percentage of US residents who reported they had received at monovalent H1N1 influenza vaccine was 20.5%, which was assumed as an overall vaccination coverage for all five schemes.
| Risk | Ages | CDC- like vaccination |
Seasonal- like vaccination |
Morbidity- based vaccination |
Mortality- based vaccination |
Mass vaccination |
|---|---|---|---|---|---|---|
| High risk | 0–4 | 33.0% | 18.8% | 44.3% | 7.5% | 20.5% |
| 5–19 | 27.5% | 11.2% | 51.7% | 17.6% | 20.5% | |
| 20–44 | 18.6% | 11.9% | 13.5% | 26.7% | 20.5% | |
| 45–64 | 18.6% | 20.0% | 7.6% | 20.5% | 20.5% | |
| 65+ | 11.2% | 36.0% | 2.5% | 15.1% | 20.5% | |
| Low risk | 0–4 | 33.0% | 27.5% | 44.3% | 7.5% | 20.5% |
| 5–19 | 27.5% | 18.8% | 51.7% | 17.6% | 20.5% | |
| 20–44 | 18.6% | 13.9% | 13.5% | 26.7% | 20.5% | |
| 45–64 | 18.6% | 21.8% | 7.6% | 20.5% | 20.5% | |
| 65+ | 11.2% | 40.6% | 2.5% | 15.1% | 20.5% | |
| Over-all | 20.5% | 20.5% | 20.5% | 20.5% | 20.5% | |